Evidence map›Paper›PMID 37720761›Full record

ArticleACS omega2023

Selection of Natural Compounds with HMGA-Interfering Activities and Cancer Cell Cytotoxicity.

Mattia Mori, Francesca Ghirga, Beatrice Amato, Luca Secco, Deborah Quaglio, Isabella Romeo, Marta Gambirasi, Alberta Bergamo, Sonia Covaceuszach, Riccardo Sgarra and 2 more

Abstract read
In one paragraph

Article in ACS omega, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Mattia MoriDepartment of Biotechnology, Chemistry and Pharmacy, University of Siena, Siena 53100, Italy.ORCID https://orcid.org/0000-0003-2398-1254
Francesca GhirgaDepartment of Chemistry and Technology of Drugs, Sapienza-University of Rome, Rome 00185, Italy.ORCID https://orcid.org/0000-0002-5591-5190
Beatrice AmatoDepartment of Life Sciences, University of Trieste, Trieste 34127, Italy.
Luca SeccoDepartment of Life Sciences, University of Trieste, Trieste 34127, Italy.ORCID https://orcid.org/0000-0001-5268-3198
Deborah QuaglioDepartment of Chemistry and Technology of Drugs, Sapienza-University of Rome, Rome 00185, Italy.ORCID https://orcid.org/0000-0001-7762-8283
Isabella RomeoDepartment of Chemistry and Technology of Drugs, Sapienza-University of Rome, Rome 00185, Italy.
Marta GambirasiDepartment of Life Sciences, University of Trieste, Trieste 34127, Italy.
Alberta BergamoDepartment of Life Sciences, University of Trieste, Trieste 34127, Italy.
Sonia CovaceuszachInstitute of Crystallography, National Research Council, Trieste Outstation, Basovizza, Trieste 34149, Italy.
Riccardo SgarraDepartment of Life Sciences, University of Trieste, Trieste 34127, Italy.
Bruno BottaDepartment of Chemistry and Technology of Drugs, Sapienza-University of Rome, Rome 00185, Italy.ORCID https://orcid.org/0000-0001-8707-4333
Guidalberto ManfiolettiDepartment of Life Sciences, University of Trieste, Trieste 34127, Italy.ORCID https://orcid.org/0000-0001-7913-2601

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

HMGA proteins are intrinsically disordered (ID) chromatin architectural factors characterized by three DNA binding domains (AT-hooks) that allow them to bind into the DNA minor groove of AT-rich stretches. HMGA are functionally involved in regulating transcription, RNA processing, DNA repair, and chromatin remodeling and dynamics. These proteins are highly expressed and play essential functions during embryonic development. They are almost undetectable in adult tissues but are re-expressed at high levels in all cancers where they are involved in neoplastic transformation and cancer progression. We focused on identifying new small molecules capable of binding into the minor groove of AT-rich DNA sequences that could compete with HMGA for DNA binding and, thus, potentially interfere with their activities. Here, a docking-based virtual screening of a unique high diversity in-house library composed of around 1000 individual natural products identified 16 natural compounds as potential minor groove binders that could inhibit the interaction between HMGA and DNA. To verify the ability of these selected compounds to compete with HMGA proteins, we screened them using electrophoretic mobility shift assays. We identified Sorocein C, a Diels-Alder (D-A)-type adducts, isolated from

Identifiers

PMID37720761
PMCPMC10500574

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.